Mesenchymal stromal cells
Mesenchymal stromal cells is a biological therapy with 26 clinical trials. Currently 4 active trials ongoing. Historical success rate of 63.6%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
18
Early Stage
6
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
58.3%
7 of 12 finished
41.7%
5 ended early
4
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
MSC Intratissular Injection in Crohn Disease Patients
Clinical Trials (26)
Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
MSC Intratissular Injection in Crohn Disease Patients
NEPHSTROM for Diabetic Kidney Disease
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection
Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation
Mesenchymal Stromal Cells in Kidney Transplant Recipients
Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome
Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease
Mesenchymal Stromal Cell Therapy in Renal Recipients
Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds
Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease
Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
MSC and Kidney Transplant Tolerance (Phase A)
MSC Therapy in Liver Transplantation
Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 26